Joel Greenblatt Ginkgo Bioworks Holdings, Inc. Transaction History

Gotham Asset Management, LLC

$6.49 Billion
Q1 2024

A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 56,871 shares of DNA stock, worth $18,767. This represents 0.0% of its overall portfolio holdings.

Number of Shares

56,871

Previous 1,350,931 95.79%

Holding current value

$18,767

Previous $2.28 Million 97.15%

% of portfolio

0.0%

Previous 0.04%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.06 - $1.67 $1.37 Million - $2.16 Million	-1,294,060 Reduced 95.79%	56,871 $65,000
Q4 2023 Feb 14, 2024	SELL	$1.26 - $1.79 $741,837 - $1.05 Million	-588,760 Reduced 30.35%	1,350,931 $2.28 Million
Q3 2023 Nov 14, 2023	BUY	$1.61 - $2.54 $630,913 - $995,354	391,872 Added 25.32%	1,939,691 $3.51 Million
Q2 2023 Aug 14, 2023	BUY	$1.14 - $1.95 $1.36 Million - $2.33 Million	1,197,031 Added 341.24%	1,547,819 $2.88 Million
Q1 2023 May 15, 2023	SELL	$1.2 - $2.19 $779,244 - $1.42 Million	-649,370 Reduced 64.93%	350,788 $466,000

Q4 2022 Feb 14, 2023	SELL	$1.63 - $3.52 $76,926 - $166,122	-47,194 Reduced 4.51%	1,000,158 $1.69 Million
Q3 2022 Nov 14, 2022	BUY	$0.73 - $3.74 $208,510 - $1.07 Million	285,631 Added 37.5%	1,047,352 $3.27 Million
Q2 2022 Aug 15, 2022	BUY	$2.2 - $4.2 $1.64 Million - $3.12 Million	743,795 Added 4149.25%	761,721 $1.81 Million
Q1 2022 May 16, 2022	BUY	$2.83 - $8.69 $50,730 - $155,776	17,926 New	17,926 $72,000

Others Institutions Holding DNA

# of Institutions

360

Shares Held

1.26B

Call Options Held

845K

Put Options Held

2.54M

View Full List

About Ginkgo Bioworks Holdings, Inc.

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $425M
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

More about DNA

Track Joel Greenblatt's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Account